Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 0 | 3 | 0 | 0 | 2 |
| Gross Profit | N/A | 3 | N/A | N/A | 2 |
| Operating Expenses | 1,012 | 910 | 1,187 | 1,039 | 1,094 |
| Operating Income | -1,012 | -907 | -1,187 | -1,039 | -1,092 |
| Other Income | 6 | 14 | 28 | -12 | 19 |
| Pre-tax Income | -1,006 | -893 | -1,159 | -1,051 | -1,073 |
| Net Income Continuous | -1,006 | -893 | -1,159 | -1,051 | -1,073 |
| Net Income | $-1,006 | $-893 | $-1,159 | $-1,051 | $-1,073 |
| EPS Basic Total Ops | -0.59 | 4.60 | -5.50 | -0.63 | -0.67 |
| EPS Basic Continuous Ops | -0.52 | -0.32 | -0.53 | -0.63 | -0.67 |
| EPS Diluted Total Ops | -0.59 | 4.60 | -5.50 | -0.63 | -0.67 |
| EPS Diluted Continuous Ops | -0.52 | -0.32 | -0.53 | -0.63 | -0.67 |
| EPS Diluted Before Non-Recurring Items | -0.59 | -0.36 | -0.55 | -0.63 | -0.67 |
| EBITDA(a) | $-1,004 | $-907 | $-1,187 | $-1,039 | $-1,092 |